BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19443132)

  • 1. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts.
    Cooper ZD; Haney M
    Drug Alcohol Depend; 2009 Aug; 103(3):107-13. PubMed ID: 19443132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marijuana's dose-dependent effects in daily marijuana smokers.
    Ramesh D; Haney M; Cooper ZD
    Exp Clin Psychopharmacol; 2013 Aug; 21(4):287-93. PubMed ID: 23937597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.
    Ilan AB; Gevins A; Coleman M; ElSohly MA; de Wit H
    Behav Pharmacol; 2005 Sep; 16(5-6):487-96. PubMed ID: 16148455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.
    Cooper ZD; Comer SD; Haney M
    Neuropsychopharmacology; 2013 Sep; 38(10):1984-92. PubMed ID: 23609132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration.
    Newmeyer MN; Swortwood MJ; Abulseoud OA; Huestis MA
    Drug Alcohol Depend; 2017 Jun; 175():67-76. PubMed ID: 28407543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.
    Lundahl LH; Greenwald MK
    Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.
    Chait LD; Zacny JP
    Psychopharmacology (Berl); 1992; 107(2-3):255-62. PubMed ID: 1319601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
    Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
    Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-9-tetrahydrocannabinol content and human marijuana self-administration.
    Chait LD
    Psychopharmacology (Berl); 1989; 98(1):51-5. PubMed ID: 2543018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
    Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J
    Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults.
    Matheson J; Sproule B; Di Ciano P; Fares A; Le Foll B; Mann RE; Brands B
    Psychopharmacology (Berl); 2020 Feb; 237(2):305-316. PubMed ID: 31637452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral THC maintenance on smoked marijuana self-administration.
    Hart CL; Haney M; Ward AS; Fischman MW; Foltin RW
    Drug Alcohol Depend; 2002 Aug; 67(3):301-9. PubMed ID: 12127201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacologic effects of daily marijuana smoking in humans.
    Perez-Reyes M; White WR; McDonald SA; Hicks RE; Jeffcoat AR; Cook CE
    Pharmacol Biochem Behav; 1991 Nov; 40(3):691-4. PubMed ID: 1666929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
    Cooper ZD; Haney M
    Psychopharmacology (Berl); 2010 Aug; 211(2):141-8. PubMed ID: 20490465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC.
    Tashkin DP; Gliederer F; Rose J; Change P; Hui KK; Yu JL; Wu TC
    Pharmacol Biochem Behav; 1991 Nov; 40(3):651-6. PubMed ID: 1666923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
    Haney M; Rabkin J; Gunderson E; Foltin RW
    Psychopharmacology (Berl); 2005 Aug; 181(1):170-8. PubMed ID: 15778874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of subject expectancy on the THC intoxication and disposition from smoked hashish cigarettes.
    Camí J; Guerra D; Ugena B; Segura J; de la Torre R
    Pharmacol Biochem Behav; 1991 Sep; 40(1):115-9. PubMed ID: 1664106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
    Haney M
    Neuropsychopharmacology; 2007 Jun; 32(6):1391-403. PubMed ID: 17091128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.